Quick Summary
GEM RTU 1.4gm Injection
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹3375
MRP: ₹13125
(You Save ₹9750)
1 VIAL(s) OF 36.84ML
74% OFF
₹3375
MRP: ₹13,125.00
Inclusive of all taxes
74% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Gemchem 1400mg Injection
NEON LABORATORI...
₹ 1057.00/injection
68% cheaper
Mygem 1400mg Injection
MYLAN PHARMACEU...
₹ 1697.00/injection
49% cheaper
Gemolife 1400mg Injection
AXIOMMAX ONCOLO...
₹ 2025.00/injection
40% cheaper
Gemfect 1.4gm Injection
AUREATE HEALTHC...
₹ 2368.00/injection
29% cheaper
Introduction to GEM RTU 1.4gm Injection
Gem RTU 1.4gm injection is a chemotherapy medication containing the active ingredient gemcitabine. It is used to treat bladder, breast, ovarian, pancreatic, and non-small cell lung cancers. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. Talk to your doctor if you have heart disease, liver disorders, kidney disorders, recently had radiotherapy, or vaccinated before taking this medicine.
Gem RTU 1.4gm injection is not recommended for adolescents and children under the age of 18. Your doctor will assess your blood cell counts and kidney and liver function each time you are given this medicine. Use effective birth control during the treatment and at least six months after the last dose. It may impair fertility in male patients. Men taking this medicine are advised not to father a child during the treatment and for 6 months after the treatment.
Tell your physician if you are on a salt-controlled diet, as this medicine contains sodium. Report to your doctor immediately if you experience shortness of breath, wheezing, changes in color or volume of urine, bleeding, or upper abdominal pain while taking gem RTU 1.4gm injection.
Uses of GEM RTU 1.4gm Injection
- Bladder cancer, in combination with cisplatin
- Ovarian cancer, in combination with carboplatin
- Breast cancer, in combination with paclitaxel
- Pancreatic cancer
- Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin
Therapeutic Effects of GEM RTU 1.4gm Injection
Gem RTU 1.4gm injection blocks the ability of cancer cells to process DNA replication, which is essential for the cells to divide and grow. This can prevent or stop the growth of cancer cells.
Interaction of GEM RTU 1.4gm Injection with other drugs
Inform your healthcare professional about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products. Certain medications interacting with gem RTU 1.4gm injection may reduce effectiveness by causing undesirable side effects.
More Information about GEM RTU 1.4gm Injection
- Keep gem RTU 1.4gm injection out of sight and reach of children.
- This medicine does not require any special storage conditions.
- Do not refrigerate or freeze.
How to consume GEM RTU 1.4gm Injection
Gem RTU 1.4gm injection is administered as an intravenous infusion into the vein. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.
Safety Advice for GEM RTU 1.4gm Injection
Breast Feeding
You must not breastfeed while being treated with gem RTU 1.4gm injection. Inform your doctor if you are breastfeeding before taking this treatment.
Alcohol
It is not advised to take alcohol while under this treatment because it may cause drowsiness and sleepiness. Talk to your doctor for more information.
Liver
You need to tell your doctor if you have any liver disorders before taking gem RTU 1.4gm injection. Your doctor may decide to adjust the dose or delay treating you depending on your liver function.
Lungs
Gem RTU 1.4gm injection is used cautiously in a patient with a lung disorder. Inform your doctor if you have any lung disease.
Driving
Gem RTU 1.4gm injection could affect your ability to drive. Avoid driving while taking this medicine. Talk to your doctor for more information.
Pregnancy
Gem RTU 1.4gm injection can cause harm to your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking the drug.
Side Effects of GEM RTU 1.4gm Injection
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious
- Pulmonary toxicity (shortness of breath, wheezing, cough)
- Hemolytic-uremic syndrome (Changes in the volume or colour of urine, increased bruising, or bleeding)
- Pain or tenderness in the upper abdomen
- Allergic reactions, rashes, fever, swelling or sores in the mouth
Common
- Nausea, vomiting
- Low blood cell count
- Loss of appetite
- Hair loss
- Swelling of ankles, feet, and fingers
- Insomnia
- Constipation, diarrhea
- Headache
- Running nose, chills
- Muscle pain, back pain
- Sweating
- hair loss
- liver problems
- blood in urine
- abnormal urine test
- Oedema (swelling of ankles, fingers, feet, face)
Word of Advice
It is not recommended to take gem RTU 1.4gm injection if you are allergic to Gemcitabine or any of its ingredients. During this treatment, your doctor may periodically monitor your complete blood counts, blood sugar, electrolytes, liver panel, and kidney parameters to prevent serious complications. This injection may impair fertility in male patients. Men taking this injection are advised not to father a child during the treatment and for 6 months after the treatment. Consult your doctor before starting this injection, and it is advised to get suggestions about fertility concerns from your doctor. It is advised for both men and women to follow proper contraceptive methods during and after the 6 months of the last dose.
FAQs about GEM RTU 1.4gm Injection
Q1.
How does gem RTU 1.4gm injection affect cancer cells differ from healthy cells?
Gem RTU 1.4gm injection affects cancer cells more than healthy cells because cancer cells have a higher rate of DNA synthesis and replication than healthy cells. It interferes with this process, which is essential for cancer cell growth and division, ultimately leading to the death of cancer cells.
Q2.
Can gem RTU 1.4gm injection be used to treat cancer in children?
No, gem RTU 1.4gm injection is not recommended for adolescents and children under the age of 18.
Q3.
What should I tell my doctor before starting gem RTU 1.4gm injection treatment?
Patients should inform their doctor of any pre-existing medical conditions, allergies, or medications they are taking before starting gem RTU 1.4gm injection treatment. It is also important to inform the doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Q4.
Are there any dietary or lifestyle changes that patients should make while taking gem RTU 1.4gm injection?
Patients may need to make dietary or lifestyle changes while taking gem RTU 1.4gm injection, such as avoiding certain foods or activities that may interfere with the medication's effectiveness or cause side effects. This should be discussed with a healthcare professional.
Q5.
Does gem RTU 1.4gm injection cure cancer?
Gem RTU 1.4gm injection help slow the growth and spread of cancer cells, but it may not cure cancer on its own. It is often used in combination with other treatments, such as surgery, radiation therapy, or other chemotherapy medications, to improve the chances of a cure or long-term remission.
Q6.
How long does gem RTU 1.4gm injection treatment last?
The duration of gem RTU 1.4gm injection treatment will depend on the type and stage of the cancer being treated, as well as the patient's overall health and response to the medication. Treatment may last several weeks or months.
Fact Box of GEM RTU 1.4gm Injection
Molecule name: Gemcitabine | Therapeutic class: Anti-Cancer |
Pharmacological class: Antimetabolites | Indications: 1. Bladder cancer, in combination with cisplatin 2. Ovarian cancer, in combination with carboplatin 3. Breast cancer, in combination with paclitaxel 4. Pancreatic cancer 5. Non-small cell lung cancer (NSCLC), alone or in combination with cisplatin |
References
- Sun Pharmaceutical Industries, Electronic medicines compendium (EMC), [Revised on May 2022] [Accessed on 20 Mar 2023], https://www.medicines.org.uk/emc/files/pil.7298.pdf
- Hospira, Inc, US Food and Drug Administration, [Revised on June 2019 [Accessed on 20 Mar 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020509s077lbl.pdf
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1700
- KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 870.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Archana Gupta
BDS
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy
